כמות מזומנים למניה pharvaris.com (PHVS)

The business resilience of Pharvaris N.V. (PHVS) is currently in question due to FDA restrictions, which have temporarily deterred capital. This cash per share chart on GURU.Markets reflects current liquidity, where 4.53 serves as the current parameter value. Pharvaris N.V. (PHVS) develops unique oral treatments for rare edema, attracting leading biochemists through an RSU system and an ethical approach to R&D.
פילוחי מדדים מקיפים ואנליטיקה עבור Pharvaris NV (PHVS)

Scaling the development of immune drugs at Pharvaris N.V. (PHVS) through center partnerships requires significant resources; therefore, the current liquidity level per share reflects the net cash balance minus liabilities. This metric allows investors to assess the company's ability to fund clinical trials without equity dilution or new loans, determining the business's fundamental margin of safety.